BACKGROUND: After sleeve gastrectomy, many surgical options are available in patients with insufficient weight loss. Duodenal switch is typically considered the operation that results in higher weight loss, although it is, perhaps unjustly, considered technically difficult and may be accompanied by severe side effects. Single-anastomosis duodenoileal bypass with sleeve gastrectomy is a simplification of the duodenal switch that may behave as a standard biliopancreatic diversion but is easier and quicker to perform. Given its effectiveness as a primary surgery we hypothesized that it would be successful as a second-step operation. The objective of this study was to analyze the weight loss and co-morbidities resolution after a single-anastomosis duodenoileal bypass (SADI) performed as a second step after sleeve gastrectomy. METHODS: Sixteen patients with an initial body mass index of 56.4 kg/m(2) and a mean excess weight loss of 39.5% after a sleeve gastrectomy were submitted to a single-anastomosis duodenoileal bypass with a 250-cm common channel. RESULTS: There were no postoperative complications. The mean excess weight loss was 72% 2 years after the second-step surgery. The complete remission rate was 88% for diabetes, 60% for hypertension, and 40% for dyslipidemia. The mean number of daily bowel movements was 2.1. One patient suffered an isolated episode of clinical hypoalbuminemia. CONCLUSION: SADI is a safe operation that offers a satisfactory weight loss for patients subjected to a previous sleeve gastrectomy. The side effects are well tolerated, and complications are minimal.
BACKGROUND: After sleeve gastrectomy, many surgical options are available in patients with insufficient weight loss. Duodenal switch is typically considered the operation that results in higher weight loss, although it is, perhaps unjustly, considered technically difficult and may be accompanied by severe side effects. Single-anastomosis duodenoileal bypass with sleeve gastrectomy is a simplification of the duodenal switch that may behave as a standard biliopancreatic diversion but is easier and quicker to perform. Given its effectiveness as a primary surgery we hypothesized that it would be successful as a second-step operation. The objective of this study was to analyze the weight loss and co-morbidities resolution after a single-anastomosis duodenoileal bypass (SADI) performed as a second step after sleeve gastrectomy. METHODS: Sixteen patients with an initial body mass index of 56.4 kg/m(2) and a mean excess weight loss of 39.5% after a sleeve gastrectomy were submitted to a single-anastomosis duodenoileal bypass with a 250-cm common channel. RESULTS: There were no postoperative complications. The mean excess weight loss was 72% 2 years after the second-step surgery. The complete remission rate was 88% for diabetes, 60% for hypertension, and 40% for dyslipidemia. The mean number of daily bowel movements was 2.1. One patient suffered an isolated episode of clinical hypoalbuminemia. CONCLUSION: SADI is a safe operation that offers a satisfactory weight loss for patients subjected to a previous sleeve gastrectomy. The side effects are well tolerated, and complications are minimal.
Authors: Austin Cottam; Daniel Cottam; Walter Medlin; Christina Richards; Samuel Cottam; Hinali Zaveri; Amit Surve Journal: Surg Endosc Date: 2015-12-22 Impact factor: 4.584
Authors: Austin Cottam; Daniel Cottam; Hinali Zaveri; Samuel Cottam; Amit Surve; Walter Medlin; Christina Richards Journal: Obes Surg Date: 2018-09 Impact factor: 4.129
Authors: Benjamin Horsley; Daniel Cottam; Austin Cottam; Samuel Cottam; Hinali Zaveri; Amit Surve; Walter Medlin Journal: Obes Surg Date: 2019-08 Impact factor: 4.129
Authors: Ramon Vilallonga; José Maria Balibrea; Anna Curell; Oscar Gonzalez; Enric Caubet; Andrea Ciudin; Angel Michael Ortiz-Zúñiga; José Manuel Fort Journal: Obes Surg Date: 2017-12 Impact factor: 4.129
Authors: Wendy A Brown; Guillermo Ponce de Leon Ballesteros; Geraldine Ooi; Kelvin Higa; Jacques Himpens; Antonio Torres; Scott Shikora; Lilian Kow; Miguel F Herrera Journal: Obes Surg Date: 2021-01-06 Impact factor: 4.129
Authors: Rosa Marti-Fernandez; Norberto Cassinello-Fernandez; Maria Desamparados Cuenca-Ramirez; Maria Lapeña-Rodriguez; Maria Carmen Fernandez-Moreno; Raquel Alfonso-Ballester; Joaquin Ortega-Serrano Journal: Obes Facts Date: 2020-06-03 Impact factor: 3.942
Authors: Austin Cottam; Daniel Cottam; Dana Portenier; Hinali Zaveri; Amit Surve; Samuel Cottam; Legrand Belnap; Walter Medlin; Christina Richards Journal: Obes Surg Date: 2017-02 Impact factor: 4.129